Tag: biomanufacturing

New Jersey Department of Labor Commissioner Robert Asaro-Angelo, Assemblywoman Tennille McCoy, Plainsboro Township Mayor Edmund Yates, Middlesex County Board of Commissioners Director Ronald Rios,...

New $195 million facility will further enhance AbbVie's active pharmaceutical ingredient (API) production capacity and capabilities in the U.S.Expansion is part of AbbVie's previously announced commitment...

Building on its success in developing continuous production at pilot-scale with the WuXiUP™ platform, WuXi Biologics has further enhanced the technology to achieve automated continuous...

WASHINGTON, Aug. 8, 2025 /PRNewswire/ -- Growth Energy—the leading voice of America's biofuel industry—is commemorating the 20th anniversary of the Renewable Fuel Standard (RFS), which...

"Market Analysis Highlights Growth Potential, Emerging Technologies, ESG Trends, and Strategic Insights in the Cell Line and Membrane Sector" BOSTON, Aug. 5, 2025 /PRNewswire/ --...

Cross-border biopharma venture targets $300M IPO valuation and UAE facility launch by Q3 2025

KIGALI, Rwanda and SAN FRANCISCO and AUBAGNE, France, July 29, 2025 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology, Ltd. (Bio Usawa), a leading African biotechnology firm, and Sartorius Stedim Biotech, a global partner of biopharmaceutical manufacturing, have announced a partnership to accelerate Africa’s biopharmaceutical industry and address the continent’s urgent, dual health burdens in infectious and non-communicable diseases.

Recorded Q2'25 consolidated revenue of KRW 1,289.9 billionRecorded Q2'25 consolidated operating profit of KRW 475.6 billionSolid momentum sustained through capacity ramp-up and stable project...

BEIJING, July 22, 2025 /PRNewswire/ -- This is a report from China.org.cn: ...

Bonatech, a leading Chinese membrane materials company, announces completion of Series A financing

Innovative Biomanufacturing Technology Deployed at World-Class Scale to Meet Growing Demand for More Sustainable, Resilient Supply Chains SAN DIEGO, July 11, 2025 /PRNewswire/ -- Geno...

CAMBRIDGE, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of Sandy Mahatme as Chief Financial Officer and Chief Business Officer, effective July 9, 2025.

COPENHAGEN, Denmark and DAVIS, Calif., July 10, 2025 /PRNewswire/ -- 21st.BIO, a leading technology partner in precision fermentation, today announced the launch of a new development...

COPENHAGEN, Denmark and DAVIS, Calif., July 10, 2025 /PRNewswire/ -- 21st.BIO, a leading technology partner in precision fermentation, today announced the launch of a new development...